ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2020年10月22日 09時00分
Source:
Eisai
エーザイ、アデュカヌマブの欧州医薬品庁への販売承認申請の提出について
東京, 2020年10月22日 - (JCN Newswire) - エーザイ株式会社(本社:東京都、代表執行役CEO:内藤晴夫)は、バイオジェン(Nasdaq: BIIB)がアルツハイマー病治療薬候補であるアデュカヌマブについて、2020年10月、欧州医薬品庁(European Medicines Agency: EMA)に販売承認申請(Marketing Authorization Application: MAA)を提出したことを、10月21日(米国東部時間)に発出した同社の2020年第3四半期決算プレスリリースにて公表しましたので、お知らせします。
本販売承認申請は、現在EMAにより承認審査に向けた申請受理の可否に関するバリデーションが行われており、その結果については改めてお知らせする予定です。
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2020/news202065.html
概要:エーザイ株式会社
詳細は www.eisai.co.jp をご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Rally Driver Hiroshi Masuoka Receives the Person of Sports Merit Award in Japan
Jan 31, 2025 15:12 JST
TANAKA PRECIOUS METAL TECHNOLOGIES Launches Visi Fine(R): A Group of Precious Metal Materials for Medical Device Components
Jan 31, 2025 11:00 JST
Mazda Production and Sales Results for December 2024 and for January through December 2024
Jan 30, 2025 16:44 JST
Lexus Announces Global Sales Results for 2024
Jan 30, 2025 15:52 JST
MHI Thermal Systems Receives 2024 Agency for Natural Resources and Energy Commissioner's Award from ECCJ for TEJ35AM Electric-Driven Transport Refrigeration Unit Integrated with Isuzu's ELF EV
Jan 30, 2025 14:13 JST
Mitsubishi Shipbuilding Receives Order for an Offshore Patrol Vessel from the Indonesian Maritime Security Agency
Jan 30, 2025 12:35 JST
Fujitsu and Asepeyo collaborate to modernise the management of occupational benefits and contingencies
Jan 30, 2025 11:56 JST
Suzuki, Daihatsu, and Toyota Decide on the Release Schedule for Mini-Commercial Van Electric Vehicles
Jan 30, 2025 10:56 JST
A Quantum Leap into Uplisting: Spectral Capital and the Next Generation of Computing
Jan 29, 2025 22:47 JST
NEC combines video analysis technology with generative AI to generate advice for improving work quality
Jan 29, 2025 10:08 JST
Japan's Telecommunications Carriers Strengthen Disaster Response by Conducting Joint Training for Shared Refueling Stations
Jan 28, 2025 17:39 JST
FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Jan 28, 2025 09:46 JST
Ogier's milestone Monte win crowns TOYOTA GAZOO Racing one-two
Jan 27, 2025 17:24 JST
Anime Tokyo Station: Let's Enjoy together!! History of Anime Series "OSHI NO KO"
Jan 27, 2025 13:00 JST
hootfolio, Inc., a Provider of Causal Analysis Technology, Launches Business Development
Jan 27, 2025 12:01 JST
Sustainable Shared Transport and Fujitsu launch open platform for joint transportation and delivery in Japan, enhancing logistics efficiency across industries
Jan 27, 2025 10:53 JST
DOCOMO to Exhibit at MWC Barcelona 2025, World's Largest Connectivity Exhibition
Jan 24, 2025 17:39 JST
Hitachi Launches Food Quality Visualization Solution with Time-Temperature Sensing Ink
Jan 24, 2025 12:40 JST
Mitsubishi Heavy Industries Aero Engines and Rolls-Royce Celebrate 20 Years of Collaboration
Jan 24, 2025 10:38 JST
World's First Successful Transmission of Huge Volume Mission Data Using 1.5 micron Optical Inter-Satellite Communication
Jan 24, 2025 09:19 JST
More Latest Release >>
Related Release
FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
1/28/2025 9:46:00 AM JST
Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company
1/22/2025 5:18:00 PM JST
FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
1/15/2025 10:03:00 AM JST
Elucidation of part of the Mechanism by which Lecanemab Slows the Progression of Alzheimer's Disease
1/7/2025 9:14:00 AM JST
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
12/23/2024 5:22:00 PM JST
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia
12/11/2024 2:45:00 PM JST
"LEQEMBI" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico
12/5/2024 11:22:00 AM JST
LEQEMBI (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea
11/28/2024 4:26:00 PM JST
Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan
11/26/2024 3:50:00 PM JST
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
11/20/2024 11:51:00 AM JST
More Press release >>